Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (1), 81-7

Tobacco and Metabolic Syndrome

Affiliations

Tobacco and Metabolic Syndrome

Yatan Pal Singh Balhara. Indian J Endocrinol Metab.

Abstract

Tobacco is a leading contributor to morbidity and mortality globally. Metabolic syndrome is a constellation of abdominal obesity, atherogenic dyslipidemia, raised blood pressure, insulin resistance (with and without glucose intolerance), pro-inflammatory state, and pro-thrombotic state. Tobacco use is associated with various core components of metabolic syndrome. It has been found to play a causal role in various pathways leading on to development this condition, the current article discusses various facets of this association.

Keywords: Metabolic syndrome; second-hand smoke; tobacco.

Conflict of interest statement

Conflict of Interest: No.

Similar articles

See all similar articles

Cited by 5 articles

References

    1. Smoking and health: Joint report of the Study Group on Smoking and Health. Science. 1957;125:1129–33. - PubMed
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Washington, DC: Oxford University Press and The World Bank; 2006. Global burden of disease and risk factors.
    1. Woodward A, Laugesen M. How many deaths are caused by second-hand cigarette smoke? Tob Control. 2001;10:383–8. - PMC - PubMed
    1. Öberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: A retrospective analysis of data from 192 countries. Lancet. 2011;377:139–46. - PubMed
    1. Geneva: World Health Organisation; 2009. WHO report on the global tobacco epidemic, 2009: Implementing smoke-free environments. France.
Feedback